Australia
· Delayed Price · Currency is AUD Vitrafy Life Sciences Company Description
Vitrafy Life Sciences Limited provides cryopreservation solutions in Australia.
Its cryopreservation technology improves the cell survival of cryopreserved biological materials, such as blood platelets used to treat trauma patients, t cells used in cancer treatments, and animal sperm used in breeding and farming.
The company provides smart freezing device, smart thawing device, and LifeChain, a sample quality management software platform, as well as smart blood bag and sperm packaging solution.
It serves animal genetics and animal reproduction suppliers; blood platelets organizations, biobanks, and points of care; and human cell and gene therapies markets.
The company has research and collaboration agreement with CSL Innovation Pty Ltd, US Army Institute of Surgical Research, Select Sires, Inc. and a Huon Aquaculture Company Pty Ltd. Vitrafy Life Sciences Limited was incorporated in 2017 and is based in South Melbourne, Australia.
| Country | Australia |
| Founded | 2017 |
| Industry | Surgical and Medical Instruments and Apparatus |
| Employees | 22 |
| CEO | Kathryn Munnings |
Contact Details
Address: 96-100 Albert Road South Melbourne, 3205 Australia | |
| Website | vitrafy.com |
Stock Details
| Ticker Symbol | VFY |
| Exchange | Australian Securities Exchange |
| Fiscal Year | July - June |
| Reporting Currency | AUD |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Kathryn Munnings | Chief Executive Officer |
| Simon Martin | Chief Financial Officer |